About: Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1988

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1988 (uk) im November 1988 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1988 (en) artículu científicu espublizáu en payares de 1988 (ast)
publication date	wds:Q70408554-A85EFE86-45E9-4A17-9F96-555758E8B17F
publication date	1988-11-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q70408554-0CC3238A-BA5F-4AD2-95E5-E1440BF3B269 wds:Q70408554-B8F9D2CC-2769-40EF-8F83-95F24EF935BF
cites work	Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy A phase II study of Cis-platinum for recurrent corpus cancer
author name string	wds:Q70408554-3AE9E040-6653-4681-801C-D3EFF49B7665 wds:Q70408554-70A38907-1698-4513-A8C2-B17B89921720 wds:Q70408554-798A1807-D924-4A0C-84A9-79B47DF4D446 wds:Q70408554-996D26F9-4B50-4A59-BAFA-5399F3C56855 wds:Q70408554-AE328B8F-32F8-4BDF-85ED-E4CB7F9328B5 wds:Q70408554-C40AFB0F-B3EE-4252-984F-F4E4742B084A
author name string	H Ball J A Blessing P Hanjani J T Thigpen A Manetta H Homesley
rdfs:label	Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (en) Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (nl)
skos:prefLabel	Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (en) Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (nl)
name	Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (en) Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (nl)
title	wds:Q70408554-74446777-C978-402A-A8BD-D921EA7DACC0
title	Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group (en)
page(s)	wds:Q70408554-AC975DF9-3982-4BAC-BDE3-CACE08677E4B
page(s)	435-438
instance of	wds:Q70408554-E569BEFB-E67C-4FBD-8613-88769D8C221A
instance of	scholarly article
main subject	wds:Q70408554-048BA614-6AA0-4348-B0E2-B83A269CC0C2 wds:Q70408554-67036B50-5041-436A-A081-7AE86EF2CBF5 wds:Q70408554-763E9953-4E86-4492-B649-FA1FBC94396F
main subject	chemotherapy gynecologic oncology phase II clinical trial
PubMed ID	wds:Q70408554-415B0654-AD2B-4298-AFC7-546DD64B9014
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3141250
PubMed ID	3141250
published in	wds:Q70408554-BF609968-C926-4EEB-B95F-C9681A9A7DBC
published in	Gynecologic Oncology
issue	wds:Q70408554-CEF7B166-F9CA-47E6-B4EC-7B1C9D8DA6D1
volume	wds:Q70408554-DE033297-A3B3-41D2-A20F-7C98C76001E6
issue	3
volume	31
DOI	wds:Q70408554-0410E5E8-BAAE-4B9A-83BA-4DC43DE00807
DOI	http://dx.doi.org/10.1016/S0090-8258(88)80028-3
DOI	10.1016/S0090-8258(88)80028-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70408554
is cites work of	A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group
is cites work of	wds:Q40463621-270DE732-3F56-4824-82B5-6FB0EB8F23B6 wds:Q24246360-66AF6B5E-C53E-4CE6-8994-C5FBD2B2FA46 wds:Q89515061-61E6A737-B901-450A-B191-F0623FACD243 wds:Q43266878-FD31D03F-F928-483D-A23A-9F4BA0BA36ED

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software